Palisade Bio, Inc. Files 8-K: Material Agreement & Equity Sales
Ticker: PALI · Form: 8-K · Filed: Jul 25, 2025 · CIK: 1357459
| Field | Detail |
|---|---|
| Company | Palisade Bio, Inc. (PALI) |
| Form Type | 8-K |
| Filed Date | Jul 25, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: material-agreement, equity-sale, corporate-action
TL;DR
Palisade Bio signed a big deal and sold stock, filing an 8-K on 7/25.
AI Summary
On July 23, 2025, Palisade Bio, Inc. entered into a material definitive agreement, the details of which are not fully disclosed in this filing. The company also reported unregistered sales of equity securities and other events. This filing was made on July 25, 2025.
Why It Matters
This 8-K filing indicates significant corporate activity for Palisade Bio, Inc., including a new material agreement and equity transactions, which could impact its financial standing and strategic direction.
Risk Assessment
Risk Level: medium — The filing mentions a material definitive agreement and unregistered sales of equity securities, which can introduce financial and regulatory risks.
Key Players & Entities
- PALISADE BIO, INC. (company) — Registrant
- July 23, 2025 (date) — Date of earliest event reported
- July 25, 2025 (date) — Filing date
- 001-33672 (company) — SEC File Number
- 52-2007292 (company) — IRS Employer Identification No.
- Seneca Biopharma, Inc. (company) — Former company name
- Neuralstem, Inc. (company) — Former company name
FAQ
What is the nature of the material definitive agreement entered into by Palisade Bio, Inc. on July 23, 2025?
The filing states that Palisade Bio, Inc. entered into a material definitive agreement on July 23, 2025, but the specific terms and details of this agreement are not disclosed in this particular 8-K filing.
What type of equity securities were sold by Palisade Bio, Inc. on or around July 23, 2025?
The filing indicates "Unregistered Sales of Equity Securities" occurred, but does not specify the type or amount of equity securities sold.
When was this 8-K form filed with the SEC?
This 8-K form was filed with the SEC on July 25, 2025.
What were Palisade Bio, Inc.'s former company names?
Palisade Bio, Inc. was formerly known as Seneca Biopharma, Inc. (name change effective January 27, 2020) and prior to that, Neuralstem, Inc. (name change effective March 24, 2006).
What is the principal business address of Palisade Bio, Inc. as listed in the filing?
The principal business address of Palisade Bio, Inc. is 7750 El Camino Real Suite 2A, Carlsbad, California, 92009.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on July 25, 2025 regarding PALISADE BIO, INC. (PALI).